$ARNA News S&P 500 back for another crack at m
Post# of 72711
Posted On: 01/13/2015 12:20:02 PM
$ARNA News
S&P 500 back for another crack at major support 11:21 a.m. Jan. 31, 2014 - Michael Ashbaugh
Arena shares surge as marketer doubles sales force for diet drug 11:41 a.m. Oct. 15, 2013 - Russ Britt
Obesity drug makers jockey for position as analysts praise Vivus 12:06 p.m. Oct. 3, 2013 - Russ Britt
Hedge funds are buying these stocks right now 1:46 p.m. July 23, 2013 - Insider Monkey
5 stocks insiders are buying 1:52 p.m. June 7, 2013 - Insider Monkey
6 gut checks before the stock market's opening bell 6:47 a.m. March 7, 2013 - Shawn Langlois
Stocks to watch Monday: Transocean, Stratasys 9:22 a.m. March 4, 2013 - Sue Chang
Arena Pharmaceuticals down 7.4% in premarket 9:11 a.m. Jan. 22, 2013 - Steve Gelsi
What 2012’s winners and losers say about 2013 6:00 a.m. Dec. 14, 2012 - Howard Gold
6 gut checks before the stock market's opening bell 6:50 a.m. Dec. 12, 2012 - Shawn Langlois
4 charts challenging resistance 7:06 a.m. Oct. 16, 2012 - The Trading Deck
Vivus sees EU regulators rejecting diet drug 12:16 p.m. Sept. 21, 2012 - MarketWatch.com
Vivus falls 11% on EU drug approval update 11:07 a.m. Sept. 21, 2012 - Val Brickates Kennedy
Arena rises as Vivus sees anti-obesity setback 7:49 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus says Europe likely to reject obesity drug 7:33 a.m. Sept. 21, 2012 - MarketWatch.com
Orexigen soars 19% on analyst buy rating 12:46 p.m. Sept. 6, 2012 - Val Brickates Kennedy
Arena jumps 12% amid takeover speculation 1:55 p.m. Aug. 14, 2012 - Val Brickates Kennedy
Arena trips Nasdaq short-sale circuit breaker 3:01 p.m. Aug. 1, 2012 - Val Brickates Kennedy
Arena Pharma share drop trips short-sale limit 2:16 p.m. Aug. 1, 2012 - Laura Mandaro
Eisai gears up for launch of Arena's diet drug 9:32 a.m. July 30, 2012 - Val Brickates Kennedy
Arena starts PAH study ralinepag 4:40 p.m. Jan. 12, 2015 - Seeking Alpha
Arena starts ralinepag PAH study 4:40 p.m. Jan. 12, 2015 - Seeking Alpha
Expect Arena's Belviq To Increase U.S. Market Share During 2015 Weight Loss Season 3:04 p.m. Jan. 12, 2015 - Seeking Alpha
A Deeper Look At Arena's Belviq Pricing 3:02 p.m. Jan. 12, 2015 - Seeking Alpha
Arena Pharmaceuticals (ARNA) Is Today's Strong On High Volume Stock 10:02 a.m. Jan. 12, 2015 - TheStreet.com
Orexigen's Contrave May Have Pricing Competition 9:13 a.m. Jan. 12, 2015 - Seeking Alpha
Arena Pharmaceuticals (ARNA) in Focus: Stock Falls 5.7% - Tale of the Tape 8:38 a.m. Jan. 12, 2015 - Zacks.com
Seeking Alpha's Biotech Weekly: Gilead Rises With Phenex, Bass's Patent Attack, And More 4:00 p.m. Jan. 9, 2015 - Seeking Alpha
Sales Of Arena's Belviq Close Out 2014 - What Will 2015 Bring? 2:49 p.m. Jan. 9, 2015 - Seeking Alpha
Arena Investors Should Watch New Pricing Of Belviq Closely 12:20 p.m. Jan. 9, 2015 - Seeking Alpha
Arena's APD334 Has Real Blockbuster Potential 11:23 a.m. Jan. 9, 2015 - Seeking Alpha
Arena Pharmaceuticals Soars on Positive Study Results - Analyst Blog 5:20 p.m. Jan. 8, 2015 - Zacks.com
Today's Perilous Reversal Stock: Arena Pharmaceuticals (ARNA) 9:46 a.m. Jan. 8, 2015 - TheStreet.com
Mid-Day Market Update: J C Penney Jumps On Strong Holiday Sales; Micron Shares Decline 12:11 p.m. Jan. 7, 2015 - benzinga.com
Arena Spikes On Pipeline News 11:02 a.m. Jan. 7, 2015 - Seeking Alpha
Arena autoimmune disease candidate successful in Phase 1b 10:41 a.m. Jan. 7, 2015 - Seeking Alpha
Why JCPenney, Dick’s and Arena Pharmaceuticals Are 3 of Today’s Best Stocks 10:34 a.m. Jan. 7, 2015 - InvestorPlace.com
Mid-Morning Market Update: Markets Surge; Monsanto Profit Tops Estimates 9:59 a.m. Jan. 7, 2015 - benzinga.com
Arena Pharmaceuticals (ARNA) Showing Signs Of A Dead Cat Bounce Today 9:45 a.m. Jan. 7, 2015 - TheStreet.com
ARNA Stock Pops, And There’s Plenty More Where That Came From 9:11 a.m. Jan. 7, 2015 - InvestorPlace.com
Reveal Insider Trading for Yahoo, PulteGroup, Arena Pharmaceuticals, SolarCity, Alcoa, and Agenus 8:45 a.m. Today - PR Newswire - PRF
Arena Pharmaceuticals Initiates Phase 2 Clinical Trial Evaluating Ralinepag for Pulmonary Arterial Hypertension 8:00 a.m. Jan. 12, 2015 - PR Newswire - PRF
Reveal Earnings Forecast for Arena Pharmaceuticals, Petrobras, Alibaba, Apple, Gilead Sciences, and Applied Materials 8:45 a.m. Jan. 9, 2015 - PR Newswire - PRF
Arena Pharmaceuticals Reports on Eisai's New Marketing Initiatives for BELVIQ® (lorcaserin HCl) CIV 8:00 a.m. Jan. 9, 2015 - PR Newswire - PRF
Critical Alerts For JC Penney, Arena Pharmaceuticals, Dick's Sporting Goods, International Business Machines and Cisco Systems Released By InvestorsObserver 9:31 a.m. Jan. 8, 2015 - PR Newswire - PRF
Insider Trading Research for Apple, Twitter, Las Vegas Sands, Google, Arena Pharmaceuticals, and J C Penney 8:45 a.m. Jan. 8, 2015 - PR Newswire - PRF
Arena Pharmaceuticals Reports Positive Results from Phase 1b Clinical Trial Evaluating APD334 for the Treatment of Autoimmune Diseases 8:00 a.m. Jan. 7, 2015 - PR Newswire - PRF
Arena Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference 8:00 a.m. Jan. 6, 2015 - PR Newswire - PRF
Technical Coverage on Biotech Stocks - Arena Pharma, XOMA, Dyax, Mast Therapeutics, and Tekmira Pharma 8:50 a.m. Jan. 2, 2015 - PR Newswire - PRF
Arena Pharmaceuticals Issued Composition of Matter Patent by United States Patent and Trademark Office for Ralinepag and Related Compounds 8:00 a.m. Nov. 25, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 8:00 a.m. Nov. 24, 2014 - PR Newswire - PRF
Technical Updates on Biotech Stocks - ImmunoGen, Lexicon Pharma, ZIOPHARM Oncology, Arena Pharma, and Regulus Therapeutics 8:40 a.m. Nov. 19, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at Stifel 2014 Healthcare Conference 8:00 a.m. Nov. 13, 2014 - PR Newswire - PRF
Lorcaserin HCl Data to be Presented at the Annual Meeting of the American Association for the Study of Liver Diseases 8:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at Credit Suisse 2014 Healthcare Conference 8:00 a.m. Nov. 5, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2014 Financial Results 6:45 a.m. Nov. 3, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Report Results of an Investigational Phase 2 Trial of Lorcaserin HCl as an Aid for Smoking Cessation 6:30 a.m. Nov. 3, 2014 - PR Newswire - PRF
Lorcaserin Data to be Presented at The Obesity Society's Annual Scientific Meeting 8:37 a.m. Oct. 31, 2014 - PR Newswire - PRF
Lorcaserin Data to be Presented at The Obesity Society's Annual Scientific Meeting 8:00 a.m. Oct. 31, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Report Results of an Investigational Pilot Study of Coadministration of Lorcaserin HCl and Phentermine HCl 6:20 p.m. Oct. 28, 2014 - PR Newswire - PRF
S&P 500 back for another crack at major support 11:21 a.m. Jan. 31, 2014 - Michael Ashbaugh
Arena shares surge as marketer doubles sales force for diet drug 11:41 a.m. Oct. 15, 2013 - Russ Britt
Obesity drug makers jockey for position as analysts praise Vivus 12:06 p.m. Oct. 3, 2013 - Russ Britt
Hedge funds are buying these stocks right now 1:46 p.m. July 23, 2013 - Insider Monkey
5 stocks insiders are buying 1:52 p.m. June 7, 2013 - Insider Monkey
6 gut checks before the stock market's opening bell 6:47 a.m. March 7, 2013 - Shawn Langlois
Stocks to watch Monday: Transocean, Stratasys 9:22 a.m. March 4, 2013 - Sue Chang
Arena Pharmaceuticals down 7.4% in premarket 9:11 a.m. Jan. 22, 2013 - Steve Gelsi
What 2012’s winners and losers say about 2013 6:00 a.m. Dec. 14, 2012 - Howard Gold
6 gut checks before the stock market's opening bell 6:50 a.m. Dec. 12, 2012 - Shawn Langlois
4 charts challenging resistance 7:06 a.m. Oct. 16, 2012 - The Trading Deck
Vivus sees EU regulators rejecting diet drug 12:16 p.m. Sept. 21, 2012 - MarketWatch.com
Vivus falls 11% on EU drug approval update 11:07 a.m. Sept. 21, 2012 - Val Brickates Kennedy
Arena rises as Vivus sees anti-obesity setback 7:49 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus says Europe likely to reject obesity drug 7:33 a.m. Sept. 21, 2012 - MarketWatch.com
Orexigen soars 19% on analyst buy rating 12:46 p.m. Sept. 6, 2012 - Val Brickates Kennedy
Arena jumps 12% amid takeover speculation 1:55 p.m. Aug. 14, 2012 - Val Brickates Kennedy
Arena trips Nasdaq short-sale circuit breaker 3:01 p.m. Aug. 1, 2012 - Val Brickates Kennedy
Arena Pharma share drop trips short-sale limit 2:16 p.m. Aug. 1, 2012 - Laura Mandaro
Eisai gears up for launch of Arena's diet drug 9:32 a.m. July 30, 2012 - Val Brickates Kennedy
Arena starts PAH study ralinepag 4:40 p.m. Jan. 12, 2015 - Seeking Alpha
Arena starts ralinepag PAH study 4:40 p.m. Jan. 12, 2015 - Seeking Alpha
Expect Arena's Belviq To Increase U.S. Market Share During 2015 Weight Loss Season 3:04 p.m. Jan. 12, 2015 - Seeking Alpha
A Deeper Look At Arena's Belviq Pricing 3:02 p.m. Jan. 12, 2015 - Seeking Alpha
Arena Pharmaceuticals (ARNA) Is Today's Strong On High Volume Stock 10:02 a.m. Jan. 12, 2015 - TheStreet.com
Orexigen's Contrave May Have Pricing Competition 9:13 a.m. Jan. 12, 2015 - Seeking Alpha
Arena Pharmaceuticals (ARNA) in Focus: Stock Falls 5.7% - Tale of the Tape 8:38 a.m. Jan. 12, 2015 - Zacks.com
Seeking Alpha's Biotech Weekly: Gilead Rises With Phenex, Bass's Patent Attack, And More 4:00 p.m. Jan. 9, 2015 - Seeking Alpha
Sales Of Arena's Belviq Close Out 2014 - What Will 2015 Bring? 2:49 p.m. Jan. 9, 2015 - Seeking Alpha
Arena Investors Should Watch New Pricing Of Belviq Closely 12:20 p.m. Jan. 9, 2015 - Seeking Alpha
Arena's APD334 Has Real Blockbuster Potential 11:23 a.m. Jan. 9, 2015 - Seeking Alpha
Arena Pharmaceuticals Soars on Positive Study Results - Analyst Blog 5:20 p.m. Jan. 8, 2015 - Zacks.com
Today's Perilous Reversal Stock: Arena Pharmaceuticals (ARNA) 9:46 a.m. Jan. 8, 2015 - TheStreet.com
Mid-Day Market Update: J C Penney Jumps On Strong Holiday Sales; Micron Shares Decline 12:11 p.m. Jan. 7, 2015 - benzinga.com
Arena Spikes On Pipeline News 11:02 a.m. Jan. 7, 2015 - Seeking Alpha
Arena autoimmune disease candidate successful in Phase 1b 10:41 a.m. Jan. 7, 2015 - Seeking Alpha
Why JCPenney, Dick’s and Arena Pharmaceuticals Are 3 of Today’s Best Stocks 10:34 a.m. Jan. 7, 2015 - InvestorPlace.com
Mid-Morning Market Update: Markets Surge; Monsanto Profit Tops Estimates 9:59 a.m. Jan. 7, 2015 - benzinga.com
Arena Pharmaceuticals (ARNA) Showing Signs Of A Dead Cat Bounce Today 9:45 a.m. Jan. 7, 2015 - TheStreet.com
ARNA Stock Pops, And There’s Plenty More Where That Came From 9:11 a.m. Jan. 7, 2015 - InvestorPlace.com
Reveal Insider Trading for Yahoo, PulteGroup, Arena Pharmaceuticals, SolarCity, Alcoa, and Agenus 8:45 a.m. Today - PR Newswire - PRF
Arena Pharmaceuticals Initiates Phase 2 Clinical Trial Evaluating Ralinepag for Pulmonary Arterial Hypertension 8:00 a.m. Jan. 12, 2015 - PR Newswire - PRF
Reveal Earnings Forecast for Arena Pharmaceuticals, Petrobras, Alibaba, Apple, Gilead Sciences, and Applied Materials 8:45 a.m. Jan. 9, 2015 - PR Newswire - PRF
Arena Pharmaceuticals Reports on Eisai's New Marketing Initiatives for BELVIQ® (lorcaserin HCl) CIV 8:00 a.m. Jan. 9, 2015 - PR Newswire - PRF
Critical Alerts For JC Penney, Arena Pharmaceuticals, Dick's Sporting Goods, International Business Machines and Cisco Systems Released By InvestorsObserver 9:31 a.m. Jan. 8, 2015 - PR Newswire - PRF
Insider Trading Research for Apple, Twitter, Las Vegas Sands, Google, Arena Pharmaceuticals, and J C Penney 8:45 a.m. Jan. 8, 2015 - PR Newswire - PRF
Arena Pharmaceuticals Reports Positive Results from Phase 1b Clinical Trial Evaluating APD334 for the Treatment of Autoimmune Diseases 8:00 a.m. Jan. 7, 2015 - PR Newswire - PRF
Arena Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference 8:00 a.m. Jan. 6, 2015 - PR Newswire - PRF
Technical Coverage on Biotech Stocks - Arena Pharma, XOMA, Dyax, Mast Therapeutics, and Tekmira Pharma 8:50 a.m. Jan. 2, 2015 - PR Newswire - PRF
Arena Pharmaceuticals Issued Composition of Matter Patent by United States Patent and Trademark Office for Ralinepag and Related Compounds 8:00 a.m. Nov. 25, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 8:00 a.m. Nov. 24, 2014 - PR Newswire - PRF
Technical Updates on Biotech Stocks - ImmunoGen, Lexicon Pharma, ZIOPHARM Oncology, Arena Pharma, and Regulus Therapeutics 8:40 a.m. Nov. 19, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at Stifel 2014 Healthcare Conference 8:00 a.m. Nov. 13, 2014 - PR Newswire - PRF
Lorcaserin HCl Data to be Presented at the Annual Meeting of the American Association for the Study of Liver Diseases 8:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at Credit Suisse 2014 Healthcare Conference 8:00 a.m. Nov. 5, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2014 Financial Results 6:45 a.m. Nov. 3, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Report Results of an Investigational Phase 2 Trial of Lorcaserin HCl as an Aid for Smoking Cessation 6:30 a.m. Nov. 3, 2014 - PR Newswire - PRF
Lorcaserin Data to be Presented at The Obesity Society's Annual Scientific Meeting 8:37 a.m. Oct. 31, 2014 - PR Newswire - PRF
Lorcaserin Data to be Presented at The Obesity Society's Annual Scientific Meeting 8:00 a.m. Oct. 31, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Report Results of an Investigational Pilot Study of Coadministration of Lorcaserin HCl and Phentermine HCl 6:20 p.m. Oct. 28, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼